vimarsana.com
Home
Live Updates
Exploiting the Vulnerabilities of High-Grade Serous Ovarian Cancer Through WEE1 Inhibition : vimarsana.com
Exploiting the Vulnerabilities of High-Grade Serous Ovarian Cancer Through WEE1 Inhibition
Joyce F. Liu, MD, MPH, provides insights on WEE1 which has emerged as a potentially targetable pathway in high-grade serous ovarian cancer.
Related Keywords
Massachusetts ,
United States ,
Boston ,
Dana Farber Cancer Institute ,
Colombo ,
Western ,
Sri Lanka ,
American ,
Joycef Liu ,
,
End Results Program ,
Zentalis Pharmaceuticals ,
Astrazeneca ,
Women Health ,
Harvard Medical School ,
Division Of Gynecologic Oncology ,
American Society Of Clinical Oncology Annual Meeting ,
National Cancer Institute Surveillance ,
Gynecologic Oncology ,
Displays Preliminary Efficacy ,
Clinical Oncology Annual Meeting ,
Gynecologic Oncology Annual Meeting ,
Cancer Institute Surveillance ,
End Results ,
Accessed May ,
Intj Mol ,
vimarsana.com © 2020. All Rights Reserved.